Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2
<b><i>Background:</i></b> The Cilostazol Stroke Prevention Study 2 (CSPS 2) showed that cilostazol significantly reduced the risk of stroke by 25.7% relative to aspirin, with significantly fewer hemorrhagic events, in patients with prior ischem...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2014
|
| 在线阅读: | https://doi.org/10.1159/000360811 https://karger.com/ced/article-pdf/37/4/296/2351895/000360811.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|